Shareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
Portfolio Pulse from
Law firm Levi & Korsinsky has filed a class action securities lawsuit against GSK plc, alleging securities fraud between February 2020 and August 2022. The lawsuit claims GSK misled investors about the Zantac withdrawal and potential cancer risks, suggesting the company knew about NDMA sources for decades before removing the drug from the market.
March 23, 2025 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The lawsuit alleges GSK misrepresented information about Zantac's cancer risks and market withdrawal, which could lead to potential financial penalties and investor trust erosion.
The lawsuit directly targets GSK's alleged misleading statements about Zantac, which could result in financial settlements, legal costs, and potential stock price depreciation.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100